Medications (Avodart GlaxcoSmithKline and Proscar Merck Co.) used in a recent study indicate potential to help slow the growth of prostate cancer. The study suggests combining medications with ongoing monitoring with cases of prostate cancer diagnosed in early stages.
The drugs are being recognized as a strategy to prevent the progression of the prostate cancer. The study suggests that drugs that shrink the prostate seem to help suppress the cancer. The study involved surveillance of about 300 men from the U.S. and Canada with low risk cancer confirmed by biopsy.
This will allow men diagnosed in early stages the time to investigate and fully understand treatment options.
Thursday, February 17, 2011
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment